REGN vs SMRT · P/E 14, rev $14.34B vs rev $152.3M
Regeneron Pharmaceuticals Inc (REGN) versus SmartRent Inc (SMRT) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
SmartRent Inc (SMRT) is a software - application company listed on US.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported SMRT revenue for 2025-12-31 was $152.3M. Net income was -$60.6M. Revenue was down 12.9% from 2024-12-31 to 2025-12-31. SMRT currently screens at market cap $208.9M.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. SMRT currently screens at market cap $208.9M.
Not investment advice. Open the REGN and SMRT stock pages for the full models.
Not investment advice.